Male human papillomavirus (HPV) vaccination rates remain very low. The study objective was to gain an understanding of the perceptions of HPV disease and acceptance/barriers to HPV vaccine by parents of boys aged 9 to 18 years. An anonymous, written survey was administered from January 1, 2011 to September 30, 2013 in private pediatric offices (PPOs) and public health clinics (PHCs) in Chicago, Illinois. A total of 230 PPO parents (PPOPs) and 286 PHC parents (PHCPs) completed the survey. Despite significant differences (P < .0001) in education level, socioeconomic status, and HPV disease and vaccine knowledge/awareness between the PPOP and PHCP, there was no difference between PPOP and PHCP who would vaccinate their sons with HPV vaccine. For both groups, health care provider recommendation was the primary influence for vaccination. The major barrier to vaccination was lack of information on HPV disease/vaccine. Health care providers need to proactively discuss and use HPV vaccine in male patients.
BasemanJGKoutskyLA.The epidemiology of human papillomavirus infections. J Clin Virol. 2005; 32(suppl):S16-S24.
2.
SatterwhiteCLTorroneEMeitesE. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40:187-193.
MunozNBoschFXde SanjoseS. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-527.
5.
PalefskyJM.Human papillomavirus–related disease in men: not just a women’s issue. J Adolesc Health. 2010:46(4 suppl):S12-S19.
6.
MoscickiABPalefskyJM.HPV in men: an update. J Low Genit Tract Dis. 2011;15:231-234.
7.
GillisonML.Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. J Adolesc Health. 2008;43(4 suppl):S52-S60.
8.
JosephDAMillerMAWuX. Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer. 2008;113(10 suppl):2892-2900.
9.
SmithJSGilbertPAMelendyARanaRKPimentaJM.Age-specific prevalence of human papillomavirus infection in males: a global review. J Adolesc Health. 2011;48:540-552.
10.
MarkowitzLEDunneEFSaraiyaMLawsonHWChessonHUngerER.Quadrivalent human papilloma virus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2):1-24.
11.
MarkowitzLEDunneEFSaraiyaM. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014;63(RR-05):1-30.
Reagan-SteinerSYankeyDJeyarajahJ. National, regional, state and selected local area vaccination coverage among adolescents aged 13 to 17 years—United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64:784-792.
14.
ReiterPLMcReeA-LGottliebSLBrewerNT.HPV vaccine for adolescent males: acceptability to parents post-vaccine licensure. Vaccine. 2010;28:6292-6297.
15.
ReiterPLMcReeA-LKadisJABrewerNT.HPV vaccine and adolescent males. Vaccine. 2011;29:5595-5602.
16.
DemspeyAFButchartASingerDClarkSDavisM.Factors associated with parental intentions for male human papillomavirus vaccination: results of a national survey. Sex Transm Dis. 2011;38:769-776.
17.
GerendMAWeibleyEBlandH.Parental response to human papillomavirus vaccine availability: uptake and intentions. J Adolesc Health. 2009;45:528-531.
18.
PerkinsRBApteGMarquezC. Factors affecting human papillomavirus vaccine use among White, Black, and Latino parents of sons. Pediatr Infect Dis J. 2013;32:e38-e44.
19.
ReiterPLMcReeA-LPepperJKChantalaKBrewerNT.Improving HPV vaccine delivery: a national study of parents and their adolescent sons. J Adolesc Health. 2012;51:32-37.
20.
PerkinsRBClarkJA.Provider’s attitudes toward human papillomavirus vaccination in young men: challenges for implementation of 2011 recommendations. Am J Mens Health. 2012;6:320-324.
21.
PerkinsRBClarkJA.What affects human papillomavirus vaccination rates? A qualitative analysis of providers’ perceptions. Women’s Health Issues. 2012;22:e379-e386.
22.
HolderNAKatzenellenbogenRMiddlemanAB.Human papillomavirus vaccines: factors that affect vaccine knowledge and delivery. J Adolesc Health. 2013;53:423-425.
23.
AllisonMADunneEFMarkowitzLE. HPV vaccination of boys in primary care practices. Acad Pediatr. 2013;13:466-474.
24.
GilkeyMBMossJLMcReeALBrewerNT.Do correlates of HPV vaccine initiation differ between adolescent boys and girls?Vaccine. 2012;30:5928-5934.
25.
MaloTLGiulianoARKahnJA. Physicians’ human papillomavirus vaccine recommendations in the context of permissive guidelines for male patients: a national study. Cancer Epidemiol Biomarkers Prev. 2014;23:2126-2135.
26.
AllisonMAHurleyLPMarkowitzL. Primary care physicians’ perspectives about HPV vaccine. Pediatrics. 2016;137:e20152488.
27.
BrabinLRobertsSAFarzanehFKitchenerHC.Future acceptance of the human papillomavirus vaccination: a survey of parental attitudes. Vaccine. 2006;24:3087-3094.
28.
MarshallHRyanPRobertonDBaghurstP.A cross-sectional survey to assess community attitudes to introduction of human papillomavirus vaccine. Aust N Z J Public Health. 2007;31:235-242.
29.
WoodhallSCLehtinenMVerhoTHuhtalaHHokkamenMKosunenE.Anticipated acceptance of HPV vaccination at the baseline of implementation: a survey of parental and adolescent knowledge and attitudes in Finland. J Adolesc Health. 2007;40:466-469.
30.
OgilvieGSRempleVPMarraF. Intention of parents to have male children vaccinated with the human papillomavirus vaccine. Sex Transm Infect. 2008;84:318-323.
31.
ZimetGDRosenthalSL.HPV vaccine and males: issues and challenges. Gynecol Oncol. 2010;117(2 suppl):S26-S31.
32.
GarciniLMGalvanTBarnack-TavlarisJL.The study of human papillomavirus (HPV) vaccine uptake from a parental perspective: a systematic review of observational studies in the United States. Vaccine. 2012;30:4588-4595.
33.
ReiterPLBrewerNTGottliebSLMcReeALSmithJS.Parents’ health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med. 2009;69:475-480.
34.
BrewerNTFazekasKI.Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45:107-114.
35.
HughesJCatesJRLiddonNSmithJSGottliebSLBrewerNT.Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev. 2009;18:363-372.
36.
MarkowitzLELiuGHaririSSteinauHDunneEFUngerER.Prevalence of HPV after introduction of the vaccination program in the United States. Pediatrics. 2016;137:e20151968.
37.
PetroskyEBocchiniJAJrHaririS. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2015;64:300-304.
